OGI Stock Analysis: Buy, Sell, or Hold?
OGI - Organigram Global Inc. Common Shares
$0.94
-0.03 (-2.96%)
▼
5d:
+0.49%
30d:
-7.91%
90d:
-33.38%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
8d
Get Alerted When OGI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OGI trading at deep discount. Market pricing in -10.9% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: OGI trading at deep discount. Market pricing in -10.9% annual earnings decline, creating value opportunity for patient investors.
In-depth Analysis How we analyze
Valuation Analysis: OGI is currently trading at $0.94, which is considered fair relative to its 30-day fair value range of $0.91 to $1.00. From a valuation perspective, the stock is trading at a discount (Forward PE: 42.7) compared to its historical average (60.3). Remarkably, the market is currently pricing in an annual earnings decline of 10.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OGI is in a strong downtrend. Immediate support is located at $0.89, while resistance sits at $0.97.
Market Sentiment: OGI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.80 (+836.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OGI is in a strong downtrend. Immediate support is located at $0.89, while resistance sits at $0.97.
Market Sentiment: OGI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.80 (+836.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.91 -
$1.00
Company Quality Score
60/100
(BUY)
Options IV Signal
39th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 39th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 836.9% below Wall St target ($8.80)
Trading Range Analysis
30-Day Trading Range
$0.91 -
$1.00
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.12
(12.3%)
Support & Resistance Levels
Support Level
$0.89
Resistance Level
$0.97
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
42.70
Wall Street Target
$8.80
(+836.9%)
Revenue Growth (YoY)
-8.9%
Profit Margin
-9.2%
Valuation Discount vs History
-10.9% cheaper
PE vs Historical
42.7 vs 60.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.9%
(market-implied from PE analysis)
1-Year Target
$0.85
(-10%)
2-Year Target
$0.76
(-19%)
3-Year Target
$0.68
(-27%)
3-Yr Target (if PE normalizes)
(PE: 43→60)
$0.97
(+3%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 42.7, Growth: -66.7%)
$0.68
(+-27%)
Base:
(SPY PE: 20.7, Growth: -66.7%)
$0.33
(-65%)
Bear:
(PE: 17.6, Growth: -66.7%)
$0.28
(-70%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 42.7 to 60.3
Stabilization Target:
$1.33
(+41.2%)
PE Expansion Potential:
+41.2%
Share & Embed Analysis
Last updated: August 03, 2026 3:05 AM ET
Data refreshes hourly during market hours. Next update: 4:05 AM
Data refreshes hourly during market hours. Next update: 4:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OGI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
